Status:
COMPLETED
Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis
Lead Sponsor:
Hanmi Pharmaceutical Company Limited
Conditions:
Vasomotor Rhinitis
Eligibility:
All Genders
12-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate efficacy and safety of Cossac L tablet in the treatment of vasomotor rhinitis
Detailed Description
randomized, double-blind, placebo-controlled, phase 3
Eligibility Criteria
Inclusion
- Diagnosis of vasomotor rhinitis
Exclusion
- Significant concomitant medical condition
- Use corticosteroids or other allergy medications during the study
- Considered by investigator as not appropriate to participate in the clinical study with othe reason
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT01509209
Start Date
May 1 2011
End Date
April 1 2013
Last Update
May 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ear, nose and throat, Boramae Hospital
Dongjak, Seoul, South Korea, 156-707